Pharma sector stocks witnessed mixed movement in early trade today, with selective buying in mid-cap stocks while large-cap players faced profit booking.
Stock Performance (as of 10:28 AM):
- Biocon: ₹393.90, up ₹11.85 (+3.10%)
- Aurobindo Pharma: ₹1,153.10, up ₹5.55 (+0.48%)
- Divis Labs: ₹5,900.05, up ₹23.20 (+0.39%)
- Alkem: ₹5,209.90, up ₹8.40 (+0.16%)
- Glenmark: ₹1,475.75, down ₹1.50 (-0.10%)
- Sun Pharma: ₹1,746.15, down ₹10.70 (-0.61%)
- Cipla: ₹1,435.60, down ₹11.60 (-0.80%)
- Mankind Pharma: ₹2,558.85, down ₹37.15 (-1.43%)
Market Insights:
- Top Gainers:
- Biocon led the rally with a 3.10% gain, likely driven by positive developments in biosimilar launches and increasing investor confidence in the company.
- Aurobindo Pharma and Divis Labs also saw moderate gains, signaling selective interest in mid-cap pharma players.
- Underperformers:
- Mankind Pharma faced the sharpest decline, losing 1.43%, as investors booked profits after a recent rally.
- Large-cap stocks like Cipla, Sun Pharma, and Torrent Pharma also faced mild pressure.
- Sectoral Trend:
- Investors are showing a cautious approach toward the pharma sector, balancing profit booking in large-caps with selective accumulation in mid-caps.
The sector remains under focus as it awaits clarity on regulatory updates and quarterly earnings outcomes, which could guide future performance.
Disclaimer: This report is for informational purposes only and should not be considered as financial advice. Please consult your financial advisor before making any investment decisions.
